Entrepreneurial Spirit, Rooted in Tradition. Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a U.S. subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) in Japan, which touts a storied reputation more than 300 years in the making. Our parent company - one of Japan’s most respected - is a research-driven pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. MTPC has discovered and produced several first-in-class medicines for serious diseases, including multiple sclerosis (MS), diabetes mellitus (DM), and amyotrophic lateral sclerosis (ALS).
MTPA is rapidly expanding its operations across all functional areas. MTPA’s commitment to patients and their communities continues with a robust late-stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, MTPA launched rare diseases treatments including RADICAVA® (edaravone) injectables in 2017, EXSERVAN™ (riluzole) oral film in 2021, and RADICAVA® (edaravone) oral suspension in 2022. The company handles research, clinical development, sales, marketing, medical affairs, and business development functions. MTPA is dedicated to improving the treatment environment for those with debilitating diseases, researching on real-world evidence, and creating hope for all facing illness.
The Senior Director, Clinical Pharmacology supports the company’s Clinical Development teams, brings expertise in oversight of Clinical Pharmacology, and integrates characteristics of ADME of the drug, pharmacometrics, and non-clinical data (ADME, toxicology) to assist in the development of the clinical pharmacology aspects of compounds from multiple therapeutic areas. The Senior Director, Clinical Pharmacology works to advance multiple compounds by integrating PK/PD and clinical data to evaluate/simulate optimal doses/regimens, exposure-response, exposure-safety analyses, etc. to support the clinical pharmacology section of product inserts. The incumbent designs and writes clinical PK protocol synopses, PK analysis plans, study reports, and Clinical Pharmacology sections of regulatory submissions. The Senior Director, Clinical Pharmacology also analyzes, interprets and integrates all available clinical data to refine the PK development plan, and actively participates in cross-functional and clinical teams by promoting clinical pharmacology, explaining/defending the PK strategy and data analyses, and providing PK deliverables according to timelines.
The Senior Director, Clinical Pharmacology role represents an outstanding opportunity to use and share your experience and pharmaceutical development knowledge in the areas of neurology and inflammation while growing your skill set in a fast-paced learning environment that includes many rare diseases.